Page last updated: 2024-08-25

chitosan and acetovanillone

chitosan has been researched along with acetovanillone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Abu Hashim, II; Aman, RM; Meshali, MM1
Abdelaziz Shaaban, A; Ibrahim Abu Hashim, I; Mohamed Anter, H; Mohamed Meshali, M; Mokhtar Aman, R1
Bakhite, EA; Hassanein, EHM; Mahmoud, NA; Sayed, AM; Shaltout, ES1
Aman, RM; Anter, HM; Elamin, KM; Hashim, IIA; Meshali, MM; Othman, DIA1

Other Studies

4 other study(ies) available for chitosan and acetovanillone

ArticleYear
Novel chitosan-based solid-lipid nanoparticles to enhance the bio-residence of the miraculous phytochemical "Apocynin".
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Nov-01, Volume: 124

    Topics: Acetophenones; Animals; Chitosan; Drug Carriers; Drug Liberation; Male; Nanoparticles; Phytochemicals; Polyvinyl Alcohol; Rats, Sprague-Dawley; Stearates; Sucrose

2018
Propitious maneuvering for delivery of the phytopharmaceutical "apocynin" to induced fulminant hepatitis in BALB/c mice: In vitro and in vivo assessments.
    International journal of pharmaceutics, 2022, Oct-15, Volume: 626

    Topics: Acetophenones; Animals; Antioxidants; Chitosan; Emulsions; Galactosamine; Lipopolysaccharides; Massive Hepatic Necrosis; Mice; Mice, Inbred BALB C; NADP; Nanoparticles; Oxidoreductases; Particle Size; Phytochemicals; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Solvents

2022
Apocynin and its chitosan nanoparticles attenuated cisplatin-induced multiorgan failure: Synthesis, characterization, and biological evaluation.
    Life sciences, 2023, Feb-01, Volume: 314

    Topics: Animals; Antioxidants; Chitosan; Cisplatin; Inflammation; Nanoparticles; Oxidative Stress; Rats

2023
Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy.
    International journal of pharmaceutics, 2023, Jan-25, Volume: 631

    Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Chitosan; Drug Carriers; Humans; Liver Neoplasms; Nanomedicine; Nanoparticles; Oxidoreductases; Particle Size; Prospective Studies

2023